Printer Friendly

Toxic shock and tampons revisited.

Toxic shock and tampons revisited

Since tampons were first linked in 1980 to toxic shock syndrome (TSS) among menstruating women, scientists have studied tampon materials as contributing risk factors, resulting in the withdrawal in 1985 of tampon products containing polyacrylate. A recent epidemiologic study conducted by CDC scientists reaffirms the connection between tampon use and the potentially fatal disease, but concludes that earlier focus on polyacrylate as a high-risk factor "may not have been the most appropriate way to reduce the risk of TSS.' In a report in the Aug. 21 JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, the authors say that a tampon's absorbency, and not its chemical composition, appears to be the main culprit. An accompanying editorial by Sidney M. Wolfe of Public Citizen Health Research Group in Washington, D.C., criticizes the Food and Drug Administration for its "dangerous delay' in completing proposed rules that require absorbency ratings on tampon packaging.
COPYRIGHT 1987 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1987, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Science News
Date:Aug 29, 1987
Words:153
Previous Article:Time from infection to AIDS computed.
Next Article:Chemical controversy goes underground.
Topics:


Related Articles
Magnesium as toxic shock key.
New mean team: flu and toxic shock.
The once and future scourge: could common anti-inflammatory drugs allow bacteria to take a deadly turn?
Toxic shock syndrome in the United States: surveillance update, 1979-1996.
Oops, I got by it again!
APPEALS COURT BLOCKS TAMPON LAWSUIT.
Early and definitive diagnosis of toxic shock syndrome by detection of marked expansion of T-cell-receptor V[beta]2-positive T cells. (Dispatches).
Putting the brakes on toxic shock.
The trouble with tampons.
Drotrecogin alfa (activated) for nonmenstrual toxic shock syndrome associated with methicillin resistant Staphylococcus aureus infection.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters